NextCell Pharma AB (OSTO:NXTCL) Change In Inventory : kr0.00 Mil (TTM As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Change In Inventory?

NextCell Pharma AB's change in inventory for the quarter that ended in Feb. 2024 was kr0.00 Mil. It means NextCell Pharma AB's inventory stayed the same from Nov. 2023 to Feb. 2024 .

NextCell Pharma AB's change in inventory for the fiscal year that ended in Aug. 2023 was kr-0.02 Mil. It means NextCell Pharma AB's inventory increased by kr0.02 Mil from Aug. 2022 to Aug. 2023 .

NextCell Pharma AB's Total Inventories for the quarter that ended in Feb. 2024 was kr0.79 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. NextCell Pharma AB's Days Inventory for the quarter that ended in Feb. 2024 was 26.18.

Inventory Turnover measures how fast the company turns over its inventory within a year. NextCell Pharma AB's Inventory Turnover for the quarter that ended in Feb. 2024 was 3.49.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. NextCell Pharma AB's Inventory-to-Revenue for the quarter that ended in Feb. 2024 was 0.34.

NextCell Pharma AB Change In Inventory Historical Data

The historical data trend for NextCell Pharma AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Change In Inventory Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Change In Inventory

Get a 7-Day Free Trial

-0.77

-0.02

NextCell Pharma AB Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

NextCell Pharma AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

NextCell Pharma AB (OSTO:NXTCL) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

NextCell Pharma AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.791	/	2.757	*	365 / 4
	=	26.18

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

NextCell Pharma AB's Inventory Turnover for the quarter that ended in Feb. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2.757	/	0.791
	=	3.49

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

NextCell Pharma AB's Inventory to Revenue for the quarter that ended in Feb. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.791	/	2.334
	=	0.34

NextCell Pharma AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB (OSTO:NXTCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

65G:Germany

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines